Efficacy, safety, and patient preference of inhaled nasal corticosteroids: a review of pertinent published data.
Most clinical studies of inhaled nasal corticosteroids have established comparable safety and efficacy; therefore, there remains little to distinguish the various products from each other in the treatment of allergic rhinitis. However, patient preference is recognized increasingly as an important factor in selecting appropriate treatment. This review discusses the different methodologies that have been used to measure patient preference for intranasal corticosteroids. Patient questionnaires and other instruments for assessment that are used to measure such preferences are discussed as well as several different study designs. Now, the challenge is to implement more studies that show the reliability and consistency of instruments used to assess patient preference.
Blaiss
M S
MS
Department of Pediatrics and Medicine, University of Tennessee, Memphis, TN, USA.
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D003257:Consumer Product Safety; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009297:Nasal Mucosa / Q000187:drug effects; D010358:Patient Participation; D017060:Patient Satisfaction; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones